Skip to content

Research review

Can omega-3 supplements reduce menstrual pain?

What did a review of 12 studies with 881 participants find?

Research review 226

Systematic review and meta-analysis

Short answer

A systematic review and meta-analysis published in 2024 found that long-chain omega-3 supplements may reduce menstrual pain. It included 12 studies with 881 participants. Study-quality limitations reduce certainty, and the mechanism of any benefit remains unproven.

What did the researchers investigate?

Researchers reviewed studies of omega-3 supplementation for dysmenorrhoea. Outcomes included pain, analgesic use and reported adverse effects; they also checked whether prostaglandins were measured. Supplements provided 300 to 1800 mg of long-chain omega-3 fatty acids daily, generally for two to three months.

What did the researchers find?

Across studies, the results suggested lower reported menstrual pain with omega-3 supplementation. Some studies also reported less use of pain medicines. None directly measured prostaglandin levels, so the review could not demonstrate that any pain reduction was caused by reduced prostaglandin production.

How certain can we be?

Study methods, doses and pain assessments differed, and many studies had methodological limitations. Treatment periods were relatively short. Evidence remains limited regarding long-term effects, optimal dose, adverse events and which groups might benefit most.

Who do the findings apply to?

The review included 881 female participants experiencing menstrual pain across 12 studies. Findings cannot automatically be extended to all pelvic pain or to specific conditions such as endometriosis and adenomyosis.

What might this mean in everyday life?

Omega-3 may be a potential adjunct for some people, but the evidence does not justify replacing established treatments or assessment of severe pain. The studies examined supplements, not the effects of eating particular foods or more fish.

How does this fit with other research?

A 2022 systematic review also examined omega-3 and primary dysmenorrhoea. The reviews address similar questions and should not be considered independent confirmations if their underlying studies overlap.

What do we still need to know?

Larger, better-controlled studies should examine dose, long-term effects, safety and mechanisms, including direct measurements of prostaglandins.

Sources

Original publication: Omega-3 long chain polyunsaturated fatty acids as a potential treatment for reducing dysmenorrhoea pain: Systematic literature review and meta-analysis. Nutrition & Dietetics (2024). DOI: 10.1111/1747-0080.12835.

Read the original publication

Additional review: Omega-3 and primary dysmenorrhoea (2022).

Source checked: 18 November 2026.

Source basis: Available abstract and bibliographic details for the systematic review and meta-analysis. Full individual studies were not independently assessed.